
Peptídeos
Subcategorias de "Peptídeos"
Foram encontrados 29795 produtos de "Peptídeos"
MAP1LC3A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAP1LC3A antibody, catalog no. 70R-2895
Pureza:Min. 95%CHAC2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CHAC2 antibody, catalog no. 70R-4300
Pureza:Min. 95%Ac-Asp-Met-Gln-Asp-H aldehyde
CAS:Ac-Asp-Met-Gln-Asp-H aldehyde is a synthetic peptide that has been shown to inhibit protein interactions with the extracellular domain of the human insulin receptor. It also has been shown to activate the receptor, which leads to increased intracellular calcium levels and increased insulin secretion. Ac-Asp-Met-Gln-Asp-H aldehyde may be used as a research tool for studying protein interactions or as an antibody labeling agent. It is highly pure and can be used in cell biology and life science laboratories.
Fórmula:C20H31N5O10SPureza:Min. 95%Peso molecular:533.55 g/molPOLR1E Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of POLR1E antibody, catalog no. 70R-3384
Pureza:Min. 95%FDXR Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FDXR antibody, catalog no. 70R-2532
Pureza:Min. 95%FAM90A1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FAM90A1 antibody, catalog no. 70R-4363
Pureza:Min. 95%IDH1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IDH1 antibody, catalog no. 70R-2495
Pureza:Min. 95%ZNF619 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF619 antibody, catalog no. 70R-8157
Pureza:Min. 95%METTL6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of METTL6 antibody, catalog no. 70R-2973
Pureza:Min. 95%C10ORF56 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C10orf56 antibody, catalog no. 70R-3372
Pureza:Min. 95%TMC2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TMC2 antibody, catalog no. 70R-6319
Pureza:Min. 95%Carbonic Anhydrase I Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CA1 antibody, catalog no. 70R-2203
Pureza:Min. 95%Ccbe1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Ccbe1 antibody, catalog no. 70R-9189
Pureza:Min. 95%ZNF276 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF276 antibody, catalog no. 20R-1110
Pureza:Min. 95%BSG Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of BSG antibody, catalog no. 70R-9879
Pureza:Min. 95%SDCBP Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SDCBP antibody, catalog no. 70R-6621
Pureza:Min. 95%TMPRSS12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TMPRSS12 antibody, catalog no. 70R-7490
Pureza:Min. 95%LRRC28 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LRRC28 antibody, catalog no. 70R-4151
Pureza:Min. 95%TADA2L Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TADA2L antibody, catalog no. 70R-7986
Pureza:Min. 95%Sar1, Ile4,8]-Angiotensin II
CAS:Sar1, Ile4,8]-Angiotensin II is a peptide that belongs to the class of angiotensins. It has been shown to activate angiotensin receptors and is used as a research tool in pharmacology and cell biology. Sar1, Ile4,8]-Angiotensin II interacts with ligands such as heparin-binding EGF-like growth factor (HB-EGF) and angiopoietin 1 (ANGPT1). The antibody against Sar1, Ile4,8]-Angiotensin II blocks the receptor binding activity of this peptide. Sar1, Ile4,8]-Angiotensin II has been shown to be an inhibitor of ion channels such as inward rectifier potassium channels.
Fórmula:C43H75N13O9Pureza:Min. 95%Peso molecular:918.14 g/molAK1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AK1 antibody, catalog no. 70R-2397
Pureza:Min. 95%AVIL Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AVIL antibody, catalog no. 70R-7947
Pureza:Min. 95%PSG5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PSG5 antibody, catalog no. 70R-5400
Pureza:Min. 95%Sesn1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Sesn1 antibody, catalog no. 70R-9301
Pureza:Min. 95%KCNQ5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCNQ5 antibody, catalog no. 70R-5180
Pureza:Min. 95%FBXO25 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FBXO25 antibody, catalog no. 70R-2788
CGRP (Human)
CAS:CGRP (calcitonin gene-related peptide) is a 37-amino acid neuropeptide that is found in humans and is widely distributed in the nervous system, particularly in sensory neurons, and is involved in the regulation of vascular tone, blood flow, pain perception, and inflammation. It is a potent vasodilator and has been implicated in the pathophysiology of several vascular disorders, including migraine headaches, cluster headaches, and hypertension.
In addition to its vascular effects, human CGRP also has neuroprotective properties and has been investigated as a potential therapeutic agent for various neurological disorders, such as Alzheimer's disease and Parkinson's disease.
Human CGRP has been extensively studied as a research tool to investigate its physiological and pathological roles in various tissues and diseases. It has also been targeted by pharmacological agents, such as CGRP antagonists and antibodies, for the treatment of migraine headaches and other conditions associated with CGRP dysfunction.
This product is available as a 0.5mg vial.Fórmula:C163H267N51O49S2Pureza:Min. 95%Peso molecular:3,789.3 g/molJAZF1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of JAZF1 antibody, catalog no. 70R-8162
Pureza:Min. 95%SLC23A3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC23A3 antibody, catalog no. 70R-6805
Pureza:Min. 95%PRKACB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PRKACB antibody, catalog no. 70R-2704
Pureza:Min. 95%LRRC24 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LRRC24 antibody, catalog no. 70R-6429
Pureza:Min. 95%ACAD9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACAD9 antibody, catalog no. 70R-10179
Pureza:Min. 95%RNMT Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RNMT antibody, catalog no. 70R-5003
Pureza:Min. 95%Bis-dPEG®5-Acid
CAS:Bis-dPEG®5-Acid is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®5-Acid is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.
Fórmula:C12H18O5SPureza:Min. 95%Peso molecular:274.33 g/molEVI2B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EVI2B antibody, catalog no. 70R-1812
Pureza:Min. 95%PPP5C Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPP5C antibody, catalog no. 70R-5672
Pureza:Min. 95%UROD Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UROD antibody, catalog no. 70R-1254
Pureza:Min. 95%4-Formyl-Benzamido-dPEG®24-TFP Ester
4-Formyl-Benzamido-dPEG®24-TFP Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. 4-Formyl-Benzamido-dPEG®24-TFP Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.
Fórmula:C65H107F4NO28Pureza:Min. 95%Peso molecular:1,426.53 g/molOccludin Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of OCLN antibody, catalog no. 70R-1721
Pureza:Min. 95%PHF6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PHF6 antibody, catalog no. 70R-9074
Pureza:Min. 95%CK1 alpha 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CSNK1A1 antibody, catalog no. 70R-3672Pureza:Min. 95%PTHLH Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PTHLH antibody, catalog no. 70R-1717Pureza:Min. 95%Leu-Gly-Gly
CAS:Leu-Gly-Gly is a cyclic peptide that binds to fibrinogen and forms stable complexes with the enzyme form of human serum albumin. It is used as a model system for studying the structure of proteins, and has been shown to bind calcium ions. Leu-Gly-Gly is also an amide and can form stable complexes with basic proteins such as fibrinogen. This peptide also has significant cytotoxicity against polymorphonuclear leucocytes, which may be due to its ability to inhibit polymerase chain activity.
Fórmula:C10H19N3O4Pureza:Min. 95%Peso molecular:245.28 g/molAzido-dPEG®12-Acid
CAS:Azido-dPEG®12-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Azido-dPEG®12-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.
Pureza:Min. 95%Peso molecular:643.72 g/molEphrin-B1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EFNB1 antibody, catalog no. 70R-6117
Pureza:Min. 95%PHLDA3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PHLDA3 antibody, catalog no. 70R-4228
Pureza:Min. 95%SARS Spike (306-515), Sf9
SARS Coronavirus is an enveloped virus containing 3 outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein takes part in the virus infection cycle and is the primary target of neutralizing antibodies. SARS Spike produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 219 amino acids (306-515 aa) and having a molecular mass of 24.7kDa.SARS Spike is fused to a 6 amino acid His tag at C-terminus and purified by proprietary chromatographic techniques. The formulation of the SARS Spike (306-515) solution (0.5mg/ml) contains Phosphate-Buffered Saline (pH 7.4) and 10% Glycerol. Biological Activity: Measured by its binding ability in a functional ELISA with Human ACE-2 (CAT# enz-1159).
One-Letter Formula: ADPRVVPSGD VVRFPNITNL CPFGEVFNAT KFPSVYAWER KKISNCVADY SVLYNSTFFS TFKCYGVSAT KLNDLCFSNV YADSFVVKGD DVRQIAPGQT GVIADYNYKL PDDFMGCVLA WNTRNIDATS TGNYNYKYRY LRHGKLRPFE RDISNVPFSP DGKPCTPPAL NCYWPLNDYG FYTTTGIGYQ PYRVVVLSFE LLNAPATVCG PKLHHHHHHPureza:Min. 95%NR2F1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NR2F1 antibody, catalog no. 70R-1936
Pureza:Min. 95%ZNF550 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF550 antibody, catalog no. 70R-8148
Pureza:Min. 95%Synaptobrevin-2 (75-78) (human, bovine, mouse, rat)
Catalogue peptide; min. 95% purity
Fórmula:C23H33N5O9Peso molecular:523.55 g/mol
